Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) Director Richard A. Heyman sold 518 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $27.54, for a total value of $14,265.72. Following the sale, the director now owns 128,585 shares of the company’s stock, […]

The Lovesac Company (NASDAQ:LOVE – Get Free Report) Director Albert Jack Krause sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 3rd. The stock was sold at an average price of $26.22, for a total value of $262,200.00. Following the transaction, the director now owns 177,849 shares in the […]

Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) insider Joseph P. Lyssikatos sold 527 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $27.54, for a total transaction of $14,513.58. Following the sale, the insider now owns 1,077,409 shares of the company’s stock, […]

Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) insider Darlene Noci sold 5,000 shares of Nuvalent stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $101.74, for a total value of $508,700.00. Following the completion of the transaction, the insider now directly owns 33,300 shares of the company’s […]

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) CEO Todd Harris sold 500 shares of the firm’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $24.00, for a total value of $12,000.00. Following the sale, the chief executive officer now owns 1,477,373 shares in the company, […]

IBEX Limited (NASDAQ:IBEX – Get Free Report) Director Gem G.P. L.P. Pinebridge II sold 20,000 shares of IBEX stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $19.24, for a total transaction of $384,800.00. Following the completion of the transaction, the director now directly owns […]